全球脂質納米顆粒市場規模研究和預測：按類型（固體脂質納米顆粒(SLN)、納米結構脂質載體(NLC)、其他）、應用、最終用戶、地區2022-2029

2021 年全球脂質納米顆粒市場價值約為 6.875 億美元，預計在 2022-2029 年預測期內將以超過 13.6% 的健康增長率增長。

脂質納米粒子是一種由脂質組成的納米粒子。 它是一種用於遞送核酸的新型藥物製劑和新型藥物遞送系統，用於治療癌症等疾病。 再加上 mRNA 疫苗製造商對脂質系統的需求激增、納米粒子在基因治療中越來越多地被用作載體，以及越來越多的製藥和生物技術公司是決定全球市場需求的主要因素。

對創新和個性化醫療的日益重視，尤其是將藥物輸送到目標部位，是市場需求的主要驅動力。 根據 Statista 的數據，2019 年全球個性化醫療市場價值約為 1.98 萬億美元，預計到 2022 年將增長至 2.77 萬億美元。 因此，對個性化醫療日益增長的偏好正在推動脂質納米顆粒作為腫瘤學和神經學相關藥物遞送的載體，加速市場增長。 此外，在預測期內，研發活動投資的增加以及市場參與者開發獨特產品的積極性不斷提高，帶來了各種有利可圖的機會。 然而，嚴格法規的實施和與使用脂質納米顆粒相關的一些副作用阻礙了整個 2022-2029 年預測期內的市場增長。

考慮進行脂質納米顆粒全球市場研究的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於對產品批准的更多關注和主要參與者的強大存在，北美在收入方面佔據了市場主導地位。 另一方面，由於人口增長、生活方式的快速變化以及對膳食補充劑的需求不斷增長等因素，預計亞太地區在預測期內將以最高的複合年增長率增長。

這項研究的目的是定義近年來各個細分市場和國家的市場規模，並預測他們在未來幾年的價值。 該報告旨在捕捉被調查國家工業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還包含供利益相關者投資的微觀市場潛在機會，以及對主要參與者的競爭格局和產品供應的深入分析。

內容

第 1 章執行摘要

• 市場概況
• 2019 年至 2029 年按細分市場劃分的全球市場、市場估計和預測
  • 脂質納米顆粒市場，按地區劃分，2019-2029 年
  • 脂質納米顆粒市場，按類型，2019-2029
  • 脂質納米顆粒市場：按應用分類，2019-2029
  • 脂質納米顆粒市場：按最終用戶分類，2019-2029 年
• 主要趨勢
• 調查方法介紹
• 調查先決條件

第 2 章脂質納米顆粒的全球市場定義和範圍

• 調查的目的
• 市場定義和範圍
  • 調查範圍
  • 工業發展
• 調查年份
• 貨幣兌換率

第3章脂質納米顆粒的全球市場動態

• 脂質納米顆粒市場影響分析（2019-2029）
  • 市場驅動因素
    • 在基因治療中越來越多地採用納米粒子作為載體
    • 更加關注創新和個性化醫療
  • 市場挑戰
    • 實施嚴格的規定
    • 與使用脂質納米顆粒相關的一些副作用
  • 市場機會
    • 增加對研發活動的投資
    • 提高市場參與者對獨特產品開發的主動性

第 4 章脂質納米顆粒的全球市場行業分析

• 波特 5 力模型
  • 供應商的議價能力
  • 買家的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭公司之間的敵對關係
• 波特 5 力模型的未來方法 (2019-2029)
• 害蟲分析
  • 政治
  • 經濟的
  • 社交
  • 技術
• 頂級投資機會
• 關鍵成功策略
• 行業專家的展望
• 分析師的結論和建議

第 5 章風險評估：COVID-19 的影響

• 評估 COVID-19 對行業的總體影響
• COVID-19 之前和 COVID-19 之後的市場情景

第 6 章脂質納米顆粒的全球市場，按類型

• 市場概況
• 脂質納米顆粒的全球市場，按類型分類的性能潛力分析
• 2019-2029 年按類型分列的脂質納米顆粒全球市場估計和預測
• 脂質納米顆粒市場、細分市場分析
  • 固體脂質納米粒 (SLN)
  • 納米結構脂質載體 (NLC)
  • 其他

第 7 章：全球脂質納米顆粒市場：按應用分類

• 市場概況
• 全球脂質納米顆粒市場：應用性能 - 潛力分析
• 2019-2029 年全球脂質納米顆粒市場、按應用估算和預測
• 脂質納米顆粒市場、細分市場分析
  • 治療藥物
  • 調查

第 8 章脂質納米顆粒的全球市場：最終用戶

• 市場概況
• 脂質納米顆粒的世界市場，最終用戶表現 - 潛力分析
• 2019-2029 年全球脂質納米顆粒市場、最終用戶的估計和預測
• 脂質納米顆粒市場、細分市場分析
  • 製藥公司、生物技術公司
  • 學術和研究機構
  • 其他

第 9 章：全球脂質納米顆粒市場：區域分析

• 脂質納米顆粒市場，按地區劃分的市場概況
• 北美
  • 美國
    • 2019-2029 年按類型估算和預測
    • 按應用分類的估計和預測，2019-2029 年
    • 2019-2029 年最終用戶的估計和預測
  • 加拿大
• 歐洲脂質納米顆粒市場概況
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 意大利
  • 其他歐洲地區
• 亞太地區脂質納米顆粒市場概況
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 韓國
  • 其他亞太地區
• 拉丁美洲脂質納米顆粒市場概況
  • 巴西
  • 墨西哥
  • 其他拉丁美洲地區
• 世界其他地區

第 10 章衝突信息

• 頂級市場策略
• 公司簡介
  • 默克公司
    • 主要信息
    • 概覽
    • 財務信息（取決於數據可用性）
    • 產品概述
    • 近期趨勢
  • Evonik Industries AG
  • Gattefosse
  • Precision NanoSystems
  • ABITEC Corporation
  • Nippon Oil & Fats Corporation
  • Lipoid GmbH
  • BASF SE
  • Dishman Group
  • IOI Oleo GmbH

第 11 章研究過程

• 研究過程
  • 數據挖掘
  • 分析
  • 市場評估
  • 驗證
  • 出版
• 調查屬性
• 調查先決條件

Global Lipid Nanoparticles Market is valued at approximately USD 687.5 million in 2021 and is anticipated to grow with a healthy growth rate of more than 13.6% over the forecast period 2022-2029. Lipid nanoparticles are a type of a nanoparticle that is composed of lipids. It is a novel pharmaceutical formulation and new pharmaceutical drug delivery system that are used are used to carry nucleic acids in the treatment of diseases such as cancer. The surging demand for lipid systems from mRNA vaccine manufacturers, rising adoption of nanoparticles in gene therapy as vector, coupled with the increasing number of pharmaceutical & biotechnology companies are the primary factors that are stipulating the market demand across the globe.

The rising emphasis on innovative and personalized medicine to deliver drugs at specifically targeted sites is a chief driving factor for the market demand. According to Statista, the global market for personalized medicine was worth approximately USD 1,980 billion in 2019 and is expected to increase to USD 2,770 billion by the year 2022. Consequentially, the increasing preference towards personalized medicines is fueling the adoption of lipid nanoparticles as a carrier in delivering oncology and neurology-related drugs, which is accelerating market growth. Moreover, the rising investment on R&D activities, as well as the increasing initiatives by market players for the development of distinct products are presenting various lucrative opportunities over the forecasting years. However, the imposition of stringent regulations and several side effects associated with the use of lipid nanoparticles are hindering the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Lipid Nanoparticles Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the growing focus on receiving product approvals and the robust presence of the major players. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to factors such as rising populations, rapidly changing lifestyles, and rising demand for nutraceutical therapies in the market space.

Major market players included in this report are:

Merck KGaA

Evonik Industries AG

Gattefosse

Precision NanoSystems

ABITEC Corporation

Nippon Oil & Fats Corporation

Lipoid GmbH

BASF SE

Dishman Group

IOI Oleo GmbH

Recent Developments in the Market:

• In October 2022, Polypeptide Therapeutic Solutions (PTS) announced the expansion of its drug delivery capabilities which includes novel nanoparticle formulation and functional lipid excipients.
• In May 2022, Gattefosse declared the establishment of a new manufacturing facility in the U.S. to manufacture lipid-based specialty ingredients for cosmetic and pharmaceutical industries.
• In June 2021, Danaher unveils the company's acquisition with the Precision NanoSystems (PNI), which aims on developing PNI mRNA technology to launch vaccines for curing unmet conditions such as cancer and genetic diseases.

Global Lipid Nanoparticles Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Type, Application, End User, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Solid Lipid Nanoparticles (SLNs)

Nanostructured Lipid Carriers (NLCs)

Others

By Application:

Therapeutics

Research

By End User:

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

RoLA

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
  • 1.2.1. Lipid Nanoparticles Market, by Region, 2019-2029 (USD Million)
  • 1.2.2. Lipid Nanoparticles Market, by Type, 2019-2029 (USD Million)
  • 1.2.3. Lipid Nanoparticles Market, by Application, 2019-2029 (USD Million)
  • 1.2.4. Lipid Nanoparticles Market, by End User, 2019-2029 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Lipid Nanoparticles Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Lipid Nanoparticles Market Dynamics

• 3.1. Lipid Nanoparticles Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing adoption of nanoparticles in gene therapy as vector
    • 3.1.1.2. Rising emphasis on innovative and personalized medicine
  • 3.1.2. Market Challenges
    • 3.1.2.1. Imposition of stringent regulations
    • 3.1.2.2. Several side effects associated with the use of lipid nanoparticles
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising investment on R&D activities
    • 3.1.3.2. Increasing initiatives by market players for the development of distinct products

Chapter 4. Global Lipid Nanoparticles Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Lipid Nanoparticles Market, by Type

• 6.1. Market Snapshot
• 6.2. Global Lipid Nanoparticles Market by Type, Performance - Potential Analysis
• 6.3. Global Lipid Nanoparticles Market Estimates & Forecasts by Type 2019-2029 (USD Million)
• 6.4. Lipid Nanoparticles Market, Sub Segment Analysis
  • 6.4.1. Solid Lipid Nanoparticles (SLNs)
  • 6.4.2. Nanostructured Lipid Carriers (NLCs)
  • 6.4.3. Others

Chapter 7. Global Lipid Nanoparticles Market, by Application

• 7.1. Market Snapshot
• 7.2. Global Lipid Nanoparticles Market by Application, Performance - Potential Analysis
• 7.3. Global Lipid Nanoparticles Market Estimates & Forecasts by Application 2019-2029 (USD Million)
• 7.4. Lipid Nanoparticles Market, Sub Segment Analysis
  • 7.4.1. Therapeutics
  • 7.4.2. Research

Chapter 8. Global Lipid Nanoparticles Market, by End User

• 8.1. Market Snapshot
• 8.2. Global Lipid Nanoparticles Market by End User, Performance - Potential Analysis
• 8.3. Global Lipid Nanoparticles Market Estimates & Forecasts by End User 2019-2029 (USD Million)
• 8.4. Lipid Nanoparticles Market, Sub Segment Analysis
  • 8.4.1. Pharmaceutical & Biotechnology Companies
  • 8.4.2. Academic & Research Institutes
  • 8.4.3. Others

Chapter 9. Global Lipid Nanoparticles Market, Regional Analysis

• 9.1. Lipid Nanoparticles Market, Regional Market Snapshot
• 9.2. North America Lipid Nanoparticles Market
  • 9.2.1. U.S. Lipid Nanoparticles Market
    • 9.2.1.1. Type breakdown estimates & forecasts, 2019-2029
    • 9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
    • 9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
  • 9.2.2. Canada Lipid Nanoparticles Market
• 9.3. Europe Lipid Nanoparticles Market Snapshot
  • 9.3.1. U.K. Lipid Nanoparticles Market
  • 9.3.2. Germany Lipid Nanoparticles Market
  • 9.3.3. France Lipid Nanoparticles Market
  • 9.3.4. Spain Lipid Nanoparticles Market
  • 9.3.5. Italy Lipid Nanoparticles Market
  • 9.3.6. Rest of Europe Lipid Nanoparticles Market
• 9.4. Asia-Pacific Lipid Nanoparticles Market Snapshot
  • 9.4.1. China Lipid Nanoparticles Market
  • 9.4.2. India Lipid Nanoparticles Market
  • 9.4.3. Japan Lipid Nanoparticles Market
  • 9.4.4. Australia Lipid Nanoparticles Market
  • 9.4.5. South Korea Lipid Nanoparticles Market
  • 9.4.6. Rest of Asia Pacific Lipid Nanoparticles Market
• 9.5. Latin America Lipid Nanoparticles Market Snapshot
  • 9.5.1. Brazil Lipid Nanoparticles Market
  • 9.5.2. Mexico Lipid Nanoparticles Market
  • 9.5.3. Rest of Latin America Lipid Nanoparticles Market
• 9.6. Rest of The World Lipid Nanoparticles Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Merck KGaA
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Product Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Evonik Industries AG
  • 10.2.3. Gattefosse
  • 10.2.4. Precision NanoSystems
  • 10.2.5. ABITEC Corporation
  • 10.2.6. Nippon Oil & Fats Corporation
  • 10.2.7. Lipoid GmbH
  • 10.2.8. BASF SE
  • 10.2.9. Dishman Group
  • 10.2.10. IOI Oleo GmbH

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Lipid Nanoparticles Market, report scope
• TABLE 2. Global Lipid Nanoparticles Market estimates & forecasts by Region 2019-2029 (USD Million)
• TABLE 3. Global Lipid Nanoparticles Market estimates & forecasts by Type 2019-2029 (USD Million)
• TABLE 4. Global Lipid Nanoparticles Market estimates & forecasts by Application 2019-2029 (USD Million)
• TABLE 5. Global Lipid Nanoparticles Market estimates & forecasts by End User 2019-2029 (USD Million)
• TABLE 6. Global Lipid Nanoparticles Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 7. Global Lipid Nanoparticles Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 8. Global Lipid Nanoparticles Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 9. Global Lipid Nanoparticles Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 10. Global Lipid Nanoparticles Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 11. Global Lipid Nanoparticles Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 12. Global Lipid Nanoparticles Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 13. Global Lipid Nanoparticles Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 14. Global Lipid Nanoparticles Market by segment, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 15. Global Lipid Nanoparticles Market by region, estimates & forecasts, 2019-2029 (USD Million)
• TABLE 16. U.S. Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 17. U.S. Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 18. U.S. Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 19. Canada Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 20. Canada Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 21. Canada Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 22. UK Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 23. UK Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 24. UK Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 25. Germany Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 26. Germany Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 27. Germany Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 28. France Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 29. France Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 30. France Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 31. Italy Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 32. Italy Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 33. Italy Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 34. Spain Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 35. Spain Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 36. Spain Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 37. RoE Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 38. RoE Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 39. RoE Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 40. China Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 41. China Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 42. China Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 43. India Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 44. India Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 45. India Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 46. Japan Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 47. Japan Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 48. Japan Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 49. South Korea Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 50. South Korea Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 51. South Korea Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 52. Australia Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 53. Australia Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 54. Australia Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 55. RoAPAC Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 56. RoAPAC Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 57. RoAPAC Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 58. Brazil Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 59. Brazil Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 60. Brazil Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 61. Mexico Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 62. Mexico Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 63. Mexico Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 64. RoLA Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 65. RoLA Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 66. RoLA Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 67. Row Lipid Nanoparticles Market estimates & forecasts, 2019-2029 (USD Million)
• TABLE 68. Row Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 69. Row Lipid Nanoparticles Market estimates & forecasts by segment 2019-2029 (USD Million)
• TABLE 70. List of secondary sources, used in the study of global Lipid Nanoparticles Market
• TABLE 71. List of primary sources, used in the study of global Lipid Nanoparticles Market
• TABLE 72. Years considered for the study
• TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Lipid Nanoparticles Market, research methodology
• FIG 2. Global Lipid Nanoparticles Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Lipid Nanoparticles Market, key trends 2021
• FIG 5. Global Lipid Nanoparticles Market, growth prospects 2022-2029
• FIG 6. Global Lipid Nanoparticles Market, porters 5 force model
• FIG 7. Global Lipid Nanoparticles Market, pest analysis
• FIG 8. Global Lipid Nanoparticles Market, value chain analysis
• FIG 9. Global Lipid Nanoparticles Market by segment, 2019 & 2029 (USD Million)
• FIG 10. Global Lipid Nanoparticles Market by segment, 2019 & 2029 (USD Million)
• FIG 11. Global Lipid Nanoparticles Market by segment, 2019 & 2029 (USD Million)
• FIG 12. Global Lipid Nanoparticles Market by segment, 2019 & 2029 (USD Million)
• FIG 13. Global Lipid Nanoparticles Market by segment, 2019 & 2029 (USD Million)
• FIG 14. Global Lipid Nanoparticles Market, regional snapshot 2019 & 2029
• FIG 15. North America Lipid Nanoparticles Market 2019 & 2029 (USD Million)
• FIG 16. Europe Lipid Nanoparticles Market 2019 & 2029 (USD Million)
• FIG 17. Asia pacific Lipid Nanoparticles Market 2019 & 2029 (USD Million)
• FIG 18. Latin America Lipid Nanoparticles Market 2019 & 2029 (USD Million)
• FIG 19. Global Lipid Nanoparticles Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable